BioCentury | Nov 24, 2014
Clinical News

BreathID: Pivotal trial started

...Exalenz began an international pivotal trial to compare BreathID vs. the use of HVPG in at...
...least 200 patients with chronic liver disease. Exalenz Bioscience Ltd. (Tel Aviv:EXEN), Modiin, Israel Product: BreathID...
BioCentury | Jul 22, 2013
Company News

Exalenz sales and marketing update

...Exalenz launched the BreathID Hp test worldwide to detect Helicobacter pylori. The real-time carbon-13 dioxide (13CO2...
...worldwide to detect Helicobacter pylori. The real-time carbon-13 dioxide (13CO2) breath test runs on Exalenz's BreathID...
Items per page:
1 - 2 of 2